Correction to: Efficacy and safety of evocalcet in Japanese peritoneal dialysis patients

  • Kazuhiko TsuruyaEmail author
  • Ryutaro Shimazaki
  • Masafumi Fukagawa
  • Tadao Akizawa
  • Evocalcet Study Group

Correction to: Clinical and Experimental Nephrology (2019) 23:739–748

The article “Efficacy and safety of evocalcet in Japanese peritoneal dialysis patients” written by Kazuhiko Tsuruya · Ryutaro Shimazaki · Masafumi Fukagawa · Tadao Akizawa on behalf of Evocalcet Study Group, was originally published electronically on the publisher’s internet portal (currently SpringerLink) on 6th April 2019 without open access.

With the author(s)’ decision to opt for Open Choice the copyright of the article changed on 20th June 2019 to © The Author(s) 2019 and the article is forthwith distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits use, duplication, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made. The original article has been corrected.


Copyright information

© The Author(s) 2019

Authors and Affiliations

  • Kazuhiko Tsuruya
    • 1
    Email author
  • Ryutaro Shimazaki
    • 2
  • Masafumi Fukagawa
    • 3
  • Tadao Akizawa
    • 4
  • Evocalcet Study Group
  1. 1.Department of NephrologyNara Medical UniversityKashiharaJapan
  2. 2.R&D Division, Kyowa Hakko Kirin Co., Ltd.TokyoJapan
  3. 3.Division of Nephrology, Endocrinology and Metabolism, Department of Internal MedicineTokai University School of MedicineIseharaJapan
  4. 4.Division of Nephrology, Department of MedicineShowa University School of MedicineTokyoJapan

Personalised recommendations